Search research articles
Contact Us
Filters
Showing results (391-400 of 630) with videos related to
Page
of 63
Sort By:
American Journal of Hematology
|
September 2, 2003
Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen
Michael Shapiro, Mariusz A Wasik, Jacqueline M Junkins-Hopkins, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 2, 2014
R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma
Zachary Frosch, Marlise R Luskin, Daniel J Landsburg, et al.
Leukemia & Lymphoma
|
August 26, 2021
Time-to-response for patients with relapsed/refractory diffuse large B cell and high grade B cell lymphoma treated with polatuzumab-based therapy
Daniel J Landsburg, Sunita D Nasta, James N Gerson, et al.
Journal of the American Chemical Society
|
December 16, 2022
Expanded [23]-Helicene with Exceptional Chiroptical Properties via an Iterative Ring-Fusion Strategy
Gavin R Kiel, Harrison M Bergman, Adrian E Samkian, et al.
American Journal of Hematology
|
April 17, 2018
The changing face of adult posttransplant lymphoproliferative disorder: Changes in histology between 1999 and 2013
Donald E Tsai, Stephen Bagley, Ran Reshef, et al.
Journal of Biomedical Optics
|
September 13, 2006
Porcine skin visible lesion thresholds for near-infrared lasers including modeling at two pulse durations and spot sizes
C P Cain, G D Polhamus, W P Roach, et al.
Frontiers in Neuroanatomy
|
June 25, 2014
Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse
Daniel J Schuster, Jaclyn A Dykstra, Maureen S Riedl, et al.
Blood
|
September 8, 2021
Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy
Elise A Chong, Cécile Alanio, Jakub Svoboda, et al.
International Journal of Hematologic Oncology
|
October 11, 2018
Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS
Sarah J Nagle, Nirav N Shah, Alex Ganetsky, et al.
Journal of the American Chemical Society
|
May 27, 2020
Expanded Helicenes as Synthons for Chiral Macrocyclic Nanocarbons
Gavin R Kiel, Katherine L Bay, Adrian E Samkian, et al.
Page
of 63
Search research articles
Search
Showing results (391-400 of 630) with videos related to
Sort By:
Page
of 63
American Journal of Hematology
|
September 2, 2003
Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen
Michael Shapiro, Mariusz A Wasik, Jacqueline M Junkins-Hopkins, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 2, 2014
R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma
Zachary Frosch, Marlise R Luskin, Daniel J Landsburg, et al.
Leukemia & Lymphoma
|
August 26, 2021
Time-to-response for patients with relapsed/refractory diffuse large B cell and high grade B cell lymphoma treated with polatuzumab-based therapy
Daniel J Landsburg, Sunita D Nasta, James N Gerson, et al.
Journal of the American Chemical Society
|
December 16, 2022
Expanded [23]-Helicene with Exceptional Chiroptical Properties via an Iterative Ring-Fusion Strategy
Gavin R Kiel, Harrison M Bergman, Adrian E Samkian, et al.
American Journal of Hematology
|
April 17, 2018
The changing face of adult posttransplant lymphoproliferative disorder: Changes in histology between 1999 and 2013
Donald E Tsai, Stephen Bagley, Ran Reshef, et al.
Journal of Biomedical Optics
|
September 13, 2006
Porcine skin visible lesion thresholds for near-infrared lasers including modeling at two pulse durations and spot sizes
C P Cain, G D Polhamus, W P Roach, et al.
Frontiers in Neuroanatomy
|
June 25, 2014
Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse
Daniel J Schuster, Jaclyn A Dykstra, Maureen S Riedl, et al.
Blood
|
September 8, 2021
Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy
Elise A Chong, Cécile Alanio, Jakub Svoboda, et al.
International Journal of Hematologic Oncology
|
October 11, 2018
Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS
Sarah J Nagle, Nirav N Shah, Alex Ganetsky, et al.
Journal of the American Chemical Society
|
May 27, 2020
Expanded Helicenes as Synthons for Chiral Macrocyclic Nanocarbons
Gavin R Kiel, Katherine L Bay, Adrian E Samkian, et al.
Page
of 63